Related Experiment Video

Updated: Aug 11, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

Beta-adrenergic receptor kinase-1 acutely regulates PTH/PTHrP receptor signalling in human osteoblastlike cells

S Fukayama1, G Kong, J L Benovic

  • 1Department of Molecular and Cellular Toxicology, Harvard School of Public Health, Boston, MA, USA. sfukayam@hsph.harvard.edu

Cellular Signalling
|October 6, 1997
PubMed

Insights

G protein-coupled receptor kinases (GRKs) play a key role in regulating the parathyroid hormone/PTH-related peptide receptor (PTH/PTHrPR). Beta-adrenergic receptor kinase-1 (beta ARK-1) activation is critical for PTH receptor downregulation and desensitization.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Endocrinology

Background:

  • G protein-coupled receptor kinases (GRKs) are crucial regulators of G protein-coupled receptor (GPCR) signaling.
  • The parathyroid hormone/PTH-related peptide receptor (PTH/PTHrPR) mediates important physiological functions.
  • Understanding the regulation of PTH/PTHrPR is vital for metabolic bone diseases.

Purpose of the Study:

  • To investigate the role of GRKs in the regulation of the PTH/PTHrPR.
  • To determine if beta-adrenergic receptor kinase-1 (beta ARK-1), a specific GRK, influences PTH/PTHrPR downregulation and desensitization.

Main Methods:

  • Established SaOS-2 cell lines with stable overexpression of a dominant-negative beta ARK-1 mutant.
  • Utilized human parathyroid hormone (hPTH (1-34)) to induce receptor downregulation and cAMP desensitization.
  • Compared the response of mutant cells to wild-type cells following PTH stimulation.

Main Results:

  • Mutant SaOS-2 cells overexpressing dominant-negative beta ARK-1 showed significantly reduced PTH/PTHrPR downregulation (up to 50%) after acute hPTH (1-34) incubation compared to wild-type cells.
  • Homologous cAMP desensitization to a second PTH challenge was blunted by up to 60% in beta ARK-1 mutant cells pretreated with PTH.
  • These findings indicate a critical role for beta ARK-1 in the acute regulation of PTH/PTHrPR.

Conclusions:

  • Activation of beta ARK-1 is essential for the acute phase (within 2 hours) of PTH-induced PTH/PTHrPR downregulation.
  • Beta ARK-1 is a critical component in the homologous cAMP desensitization of the PTH/PTHrPR.
  • These findings highlight GRKs as key players in the intricate regulatory mechanisms of the PTH/PTHrPR signaling pathway.

More Related Videos

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro09:41

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Published on: March 17, 2023

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: